Literature DB >> 17827068

Monocyte chemoattractant protein 1 contributes to an adequate immune response in influenza pneumonia.

Mark C Dessing1, Koenraad F van der Sluijs, Sandrine Florquin, Tom van der Poll.   

Abstract

Monocyte chemoattractant protein 1 (MCP-1) and its receptor CCR2 have been shown to play an import role in leukocyte recruitment to sites of infection and inflammation. To investigate the role of MCP-1 during infection with influenza we inoculated wild-type (WT) and MCP-1 knockout (KO) mice with a non-lethal dose of a mouse adapted strain of influenza A. Influenza infection of WT mice resulted in a profound increase in pulmonary MCP-1 levels. MCP-1 KO mice had enhanced weight loss and did not fully regain their body weight during the 14-day observation period. In addition, MCP-1 KO mice demonstrated elevated viral loads 8 days after infection, which was accompanied by reduced leukocyte recruitment into the infected lungs, primarily caused by a diminished influx of macrophages and granulocytes. Moreover, pulmonary levels of IgA were reduced in MCP-1 KO mice. The pulmonary concentrations of tumor necrosis factor-alpha, interleukin-6, macrophage inflammatory protein 2 and interferon-gamma were higher in MCP-1 KO mice. This study shows that MCP-1 contributes to an adequate protective immune response against influenza infection in mice.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17827068     DOI: 10.1016/j.clim.2007.08.001

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  42 in total

1.  Lung development and the host response to influenza A virus are altered by different doses of neonatal oxygen in mice.

Authors:  Bradley W Buczynski; Min Yee; B Paige Lawrence; Michael A O'Reilly
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-03-09       Impact factor: 5.464

Review 2.  Into the eye of the cytokine storm.

Authors:  Jennifer R Tisoncik; Marcus J Korth; Cameron P Simmons; Jeremy Farrar; Thomas R Martin; Michael G Katze
Journal:  Microbiol Mol Biol Rev       Date:  2012-03       Impact factor: 11.056

3.  Mapping the pulmonary environment of animals protected from virulent H1N1 influenza infection using the TLR-2 agonist Pam₂Cys.

Authors:  Edin J Mifsud; Amabel C L Tan; Patrick C Reading; David C Jackson
Journal:  Immunol Cell Biol       Date:  2015-08-14       Impact factor: 5.126

4.  A macrophage subpopulation recruited by CC chemokine ligand-2 clears apoptotic cells in noninfectious lung injury.

Authors:  Jiurong Liang; Yoosun Jung; Robert M Tighe; Ting Xie; Ningshan Liu; Maura Leonard; Michael Dee Gunn; Dianhua Jiang; Paul W Noble
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-01-27       Impact factor: 5.464

5.  Monocytes Represent One Source of Bacterial Shielding from Antibiotics following Influenza Virus Infection.

Authors:  Karl J Fischer; Vijaya Kumar Yajjala; Shruti Bansal; Christopher Bauer; Ruiling Chen; Keer Sun
Journal:  J Immunol       Date:  2019-02-11       Impact factor: 5.422

Review 6.  How the Respiratory Epithelium Senses and Reacts to Influenza Virus.

Authors:  Kambez H Benam; Laura Denney; Ling-Pei Ho
Journal:  Am J Respir Cell Mol Biol       Date:  2019-03       Impact factor: 6.914

7.  MARCO regulates early inflammatory responses against influenza: a useful macrophage function with adverse outcome.

Authors:  Sanjukta Ghosh; David Gregory; Alexia Smith; Lester Kobzik
Journal:  Am J Respir Cell Mol Biol       Date:  2011-05-11       Impact factor: 6.914

8.  Localization of type I interferon receptor limits interferon-induced TLR3 in epithelial cells.

Authors:  Jonathan M Ciencewicki; Luisa E Brighton; Ilona Jaspers
Journal:  J Interferon Cytokine Res       Date:  2009-05       Impact factor: 2.607

9.  Cytokine and chemokine response in children with the 2009 pandemic influenza A (H1N1) virus infection.

Authors:  T Takano; H Tajiri; Y Kashiwagi; S Kimura; H Kawashima
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-09-06       Impact factor: 3.267

10.  MCP-1 antibody treatment enhances damage and impedes repair of the alveolar epithelium in influenza pneumonitis.

Authors:  T Narasaraju; H H Ng; M C Phoon; Vincent T K Chow
Journal:  Am J Respir Cell Mol Biol       Date:  2009-07-17       Impact factor: 6.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.